Granite Investment Partners, LLC Harrow Health, Inc. Transaction History

Granite Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.5 - $7.31 $85,169 - $177,881	-24,334 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$4.6 - $7.88 $739,353 - $1.27 Million	-160,729 Reduced 86.85%	24,334 $189,000
Q3 2019 Nov 12, 2019	BUY	$4.89 - $8.0 $249,942 - $408,904	51,113 Added 38.16%	185,063 $1.04 Million
Q2 2019 Aug 07, 2019	SELL	$4.2 - $8.7 $495,154 - $1.03 Million	-117,894 Reduced 46.81%	133,950 $1.17 Million
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $1.2 Million - $1.79 Million	251,844 New	251,844 $1.25 Million

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.15B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.